Discontinuation of oral semaglutide due to adverse effects: a database study on Japanese individuals with type 2 diabetes
{{output}}
The global prevalence of diabetes continues to rise, necessitating advancements in treatment, such as glucagon-like peptide-1 receptor agonists. While oral semaglutide has demonstrated comparable efficacy to injectable formulations, gastrointestinal symptoms r... ...
